PNV-DHA
Active substance: ASCORBIC ACID, CALCIUM, FERROUS FUMARATE, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL ACETATE, DL-, PYRIDOXINE, FOLIC ACID, DOCONEXENT
CAPSULE, GELATIN COATED · ASCORBIC ACID 28 mg/1, CALCIUM 160 mg/1, FERROUS FUMARATE 27 mg/1, CHOLECALCIFEROL 400 [iU]/1, .ALPHA.-TOCOPHEROL ACETATE, DL- 30 [iU]/1, PYRIDOXINE 25 mg/1, FOLIC ACID 1.25 mg/1, DOCONEXENT 300 mg/1
United StatesActive
Marketing holder: Acella Pharmaceuticals, LLC
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
Composition
- ASCORBIC ACID · 28 mg/1
- CALCIUM · 160 mg/1
- FERROUS FUMARATE · 27 mg/1
- CHOLECALCIFEROL · 400 [iU]/1
- .ALPHA.-TOCOPHEROL ACETATE, DL- · 30 [iU]/1
- PYRIDOXINE · 25 mg/1
- FOLIC ACID · 1.25 mg/1
- DOCONEXENT · 300 mg/1
Registration
- Registration number
- 42192-323
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 42192-323 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 42192-323 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 42192-323 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 42192-323 · Verified 2026-10-09 · open in source
- ingredients.2 · openFDA NDC · 42192-323 · Verified 2026-10-09 · open in source
- ingredients.3 · openFDA NDC · 42192-323 · Verified 2026-10-09 · open in source
- ingredients.4 · openFDA NDC · 42192-323 · Verified 2026-10-09 · open in source
- ingredients.5 · openFDA NDC · 42192-323 · Verified 2026-10-09 · open in source
- ingredients.6 · openFDA NDC · 42192-323 · Verified 2026-10-09 · open in source
- ingredients.7 · openFDA NDC · 42192-323 · Verified 2026-10-09 · open in source